BioCentury | Sep 8, 2003
Regulation

PDE-4 inhibitors

...GlaxoSmithKline Ariflo COPD Under review for COPD Altana Roflumilast Asthma, COPD Ph III Pfizer Otsuka OPC-6535...
BioCentury | Jul 28, 2003
Clinical News

OPC-6535: Phase III

...trials will enroll 750 patients in total. Otsuka Pharmaceutical Co. Ltd. , Tokyo, Japan Product: OPC-6535...
BioCentury | Jul 22, 2003
Clinical News

Otsuka starts ulcerative colitis Phase III

...Otsuka (Tokyo, Japan) began two Phase III trials of its OPC-6535 , a phosphodiesterase 4 (PDE...
Items per page:
1 - 3 of 3